Hepatic cell encapsulation using a decellularized liver scaffold

Biomedical Engineering Letters

Volumn 5, Issue 1, 2015, Pages 58-64

  Ghim, Jinn Hoon ^a   Hussein, Kamal Hany ^a   Park, Kyung Mee ^a   Woo, Heung Myong ^a,b  

^a Kangwon National University   (South Korea)

^b HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

Decellularization; Decellularized liver scaffold; Encapsulation; Liver disease; Microstructure

Indexed keywords

BIOCOMPATIBILITY; BIOLOGICAL MATERIALS; BIOMATERIALS; BLOOD VESSELS; CELL CULTURE; CELLS; CYTOLOGY; ENCAPSULATION; MICROSTRUCTURE; SODIUM DODECYL SULFATE; SODIUM SULFATE; TISSUE ENGINEERING;

3-DIMENSIONAL STRUCTURES; CELL DELIVERY SYSTEMS; DECELLULARIZATION; DECELLULARIZED LIVERS; HISTOLOGICAL ANALYSIS; LIVER DISEASE; NATIVE EXTRACELLULAR MATRIX; POROUS MICROSTRUCTURE;

SCAFFOLDS (BIOLOGY);

ADULT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CELL ENCAPSULATION; CELL SURVIVAL; DECELLULARIZED LIVER SCAFFOLD; EXTRACELLULAR MATRIX; HISTOLOGY; HUMAN; HUMAN CELL; LIVER CELL; LIVER DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; TISSUE SCAFFOLD;

EID: 84928114408     PISSN: 20939868     EISSN: 2093985X     Source Type: Journal    
DOI: 10.1007/s13534-015-0176-0     Document Type: Article

References (43)

1. Elizabeth J. Cellular transplantation for liver diseases. Gastroenterol Res. 2008; 1(1):8–13.
2. Dixit V, Darvasi R, Arthur M, Brezina M, Lewin K, Gitnick G. Restoration of liver function in gunn rats without immunosuppression using transplanted microencapsulated hepatocytes. Hepatology. 1990; 12(6):1342–9.
3. Zhao Y, Xu Y, Zhang B, Wu X, Xu F, Liang W, Du X, Li R. In vivo generation of thick, vascularized hepatic tissue from collagen hydrogel-based hepatic units. Tissue Eng Part C Methods. 2010; 16(4):653–9.
4. Fan J, Shang Y, Yuan Y, Yang J. Preparation and characterization of chitosan/galactosylated hyaluronic acid scaffolds for primary hepatocytes culture. J Mater Sci Mater Med. 2010; 21(1):319–27.
5. Semino CE, Merok JR, Crane GG, Panagiotakos G, Zhang S. Functional differentiation of hepatocyte-like spheroid structures from putative liver progenitor cells in three-dimensional peptide scaffolds. Differentiation. 2003; 71(4–5):262–70.
6. Li RH. Materials for immunoisolated cell transplantation. Adv Drug Deliv Rev. 1998; 33(1–2):87–109.
7. Rokstad AM, Lacík I, de Vos P, Strand BL. Advances in biocompatibility and physico-chemical characterization of microspheres for cell encapsulation. Adv Drug Deliv Rev. 2014; 67–68:111–30.
8. Ratner BD. The biocompatibility manifesto: biocompatibility for the twenty-first century. J Cardiovasc Transl Res. 2011; 4(5):523–7.
9. Turner AE, Flynn LE. Design and characterization of tissuespecific extracellular matrix-derived microcarriers. Tissue Eng Part C Methods. 2012; 18(3):186–97.
10. Sgroi A, Mai G, Morel P, Baertschiger RM, Gonelle-Gispert C, Serre-Beinier V, Buhler LH. Transplantation of encapsulated hepatocytes during acute liver failure improves survival without stimulating native liver regeneration. Cell Transplant. 2011; 20(11–12):1791–803.
11. Liu ZC, Chang TM. Intrasplenic transplantation of bioencapsulated mesenchymal stem cells improves the recovery rates of 90% partial hepatectomized rats. Stem Cells Int. 2012; 2012:697094.
12. Zanin MP, Pettingill LN, Harvey AR, Emerich DF, Thanos CG, Shepherd RK. The development of encapsulated cell technologies as therapies for neurological and sensory diseases. J Control Release. 2012; 160(1):3–13.
13. Harm S, Stroble K, Hartmann J, Falkenhagen D. Alginateencapsulated human hepatoma C3A cells for use in a bioartificial liver device - the hybrid-MDS. Int J Artif Organs. 2009; 32(11):769–78.
14. Paul A, Chen G, Khan A, Rao VT, Shum-Tim D, Prakash S. Genipin-cross-linked microencapsulated human adipose stem cells augment transplant retention resulting in attenuation of chronically infarcted rat heart fibrosis and cardiac dysfunction. Cell Transplant. 2012; 21(12):2735–51.
15. Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C, Luca G, Basta G, Calafiore R. Preparation and in vitro and in vivo characterization of composite microcapsules for cell encapsulation. Int J Pharm. 2006; 324(1):27–36.
16. Hammond JS, Gilbert TW, Howard D, Zaitoun A, Michalopoulos G, Shakesheff KM, Beckingham IJ, Badylak SF. Scaffolds containing growth factors and extracellular matrix induce hepatocyte proliferation and cell migration in normal and regenerating rat liver. J Hepatol. 2011; 54(2):279–87.
17. Oe S, Fukunaka Y, Hirose T, Yamaoka Y, Tabata Y. A trial on regeneration therapy of rat liver cirrhosis by controlled release of hepatocyte growth factor. J Control Release. 2003; 88(2):193–200.
18. Davis MW, Vacanti JP. Toward development of an implantable tissue engineered liver. Biomaterials. 1996; 17(3):365–72.
19. Freimark D, Pino-Grace P, Pohl S, Weber C, Wallrapp C, Geigle P, Pörtner R, Czermak P. Use of encapsulated stem cells toovercome the bottleneck of cell availability for cell therapy approaches. Transfus Med Hemother. 2010; 37(2):66–73.
20. Fiegel HC, Kaufmann PM, Bruns H, Kluth D, Horch RE, Vacanti JP, Kneser U. Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory. J Cell Mol Med. 2008; 12(1):56–66.
21. Ji R, Zhang N, You N, Li Q, Liu W, Jiang N, Liu J, Zhang H, Wang D, Tao K, Dou K. The differentiation of MSCs into functional hepatocyte-like cells in a liver biomatrix scaffold and their transplantation into liver-fibrotic mice. Biomaterials. 2012; 33(35):8995–9008.
22. de Vos P, Lazarjani HA, Poncelet D, Faas MM. Polymers in cell encapsulation from an enveloped cell perspective. Adv Drug Deliv Rev. 2014; 67–8:15–34.
23. Wang Y, Cui CB, Yamauchi M, Miguez P, Roach M, Malavarca R, Costello MJ, Cardinale V, Wauthier E, Barbier C, Gerber DA, Alvaro D, Reid LM. Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissue-specific biomatrix scaffolds. Hepatology. 2011; 53(1):293–305.
24. Sasisekharan R, Raman R, Prabhakar V. Glycomics approach to structure-function relationships of glycosaminoglycans. Annu Rev Biomed Eng. 2008; 8:181–231.
25. Uygun BE, Soto-Gutierrez A, Yagi H, zamis ML, Guzzardi MA, Shulman C, Milwid J, Kobayashi N, Tilles A, Berthiaume F, Hertl M, Nahmias Y, Yarmush ML, Uygun K. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med. 2010; 16(7):814–20.
26. Bao J, Shi Y, Sun H, Yin X, Yang R, Li L, Chen X, Bu H. Construction of a portal implantable functional tissue-engineered liver using perfusion-decellularized matrix and hepatocytes in rats. Cell Transplant. 2011; 20(5):753–66.
27. Shirakigawa N, Takei T, Ijima H. Base structure consisting of an endothelialized vascular-tree network and hepatocytes for whole liver engineering. J Biosci Bioeng. 2013; 116(6):740–5.
28. Hussein KH, Park KM, Teotia PK, Yang JW, Kim HM, Hong SH, Yang SR, Park IC, Park SM, Woo HM. Fabrication of a biodegradable xenoantigen-free rat liver scaffold for potential drug screening applications. Transplant Proc. 2013; 45(8):3092–6.
29. Rokstad AM, Strand B, Rian K, Steinkjer B, Kulseng B, Skjåk-Braek G, Espevik T. Evaluation of different types of alginate microcapsules as bioreactors for producing endostatin. Cell Transplant. 2003; 12(4):351–64.
30. Kedem A, Perets A, Gamlieli-Bonshtein I, Dvir-Ginzberg M, Mizrahi S, Cohen S. Vascular endothelial growth factorreleasing scaffolds enhance vascularization and engraftment of hepatocytes transplanted on liver lobes. Tissue Eng. 2005; 11(5- 6):715–22.
31. Madden LR, Mortisen DJ, Sussman EM, Dupras SK, Fugate JA, Cuy JL, Hauch KD, Laflamme MA, Murry CE, Ratner BD. Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc Natl Acad Sci USA. 2010; 107(34):15211–6.
32. Bryers JD, Giachelli CM, Ratner BD. Engineering biomaterialsto integrate and heal: the biocompatibility paradigm shifts. Biotechnol Bioeng. 2012; 109(8):1898–911.
33. Griffith CK, Miller C, Sainson RC, Calvert JW, Jeon NL, Hughes CC, George SC. Diffusion limits of an in vitro thick prevascularized tissue. Tissue Eng. 2005; 11(1–2):257–66.
34. Michalopoulos GK. Liver regeneration. J Cell Physiol. 2007; 213(2):286–300.
35. Roos F, Ryan AM, Chamow SM, Bennett GL, Schwall RH. Induction of liver growth in normal mice by infusion of hepatocyte growth factor/scatter factor. Am J Physiol. 1995;268(2 Pt 1): G380–6.
36. Webber E, Godowski PJ, Fausto N. In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology. 1994; 19(2):489–97.
37. Ishii T, Sato M, Sudo K, Suzuki M, Nakai H, Hishida T, Niwa T, Umezu K, Yuasa S. Hepatocyte growth factor stimulates liver regeneration and elevates blood protein levels in normal and partially hepatectomized rats. J Biochem. 1995; 117(5):1105–12.
38. Liu ML, Mars WM, Zarnegar R, Michalopoulos GK. Collagenase pretreatment and the mitogenic effects of hepatocyte growth factor and transforming growth factor in adult liver. Hepatology. 1994; 19(6):1521–7.
39. Fujiwara K, Nagoshi S, Ohno A, Hirata K, Ohta Y, Mochida S, Tomiya T, Higashio K, Kurokawa K. Stimulation of liver growth by exogenous human hepatocyte growth factor in norma and partially hepatectomised rats. Hepatology. 1993; 18(6):1443–9.
40. Patijn GA, Lieber A, Schowalter DB, Schwall R, Kay MA. Hepatocte growth factor induces hepatocyte proliferation in vivo and allows for efficient retro-viral mediated gene transfer in mice. Hepatology. 1998; 28(3):707–16.
41. Fausto N. Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology. 2004; 39(6):1477–87.
42. Sellaro TL, Ravindra AK, Stolz DB, Badylak SF. Maintenance of hepatic sinusoidal endothelial cell phenotype in vitro using organ-specific extracellular matrix scaffolds. Tissue Eng. 2007; 13(9):2301–10.
43. Skardal A, Smith L, Bharadwaj S, Atala A, Soker S, Zhang Y. Tissue specific synthetic ECM hydrogels for 3-D in vitro maintenance of hepatocyte function. Biomaterials. 2012; 33(18):4565–75.